Evidence map›Paper›PMID 37781395›Full record

ArticleFrontiers in immunology2023

Human leukocyte antigen association in systemic sclerosis patients: our experience at a tertiary care center in North India.

Sanghamitra Machhua, Shefali Khanna Sharma, Yashwant Kumar, Surjit Singh, Ritu Aggarwal, Shashi Anand, Manoj Kumar, Heera Singh, Ranjana Walker Minz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sanghamitra MachhuaDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Shefali Khanna SharmaDepartment of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Yashwant KumarDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Surjit SinghAllergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Ritu AggarwalDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Shashi AnandDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Manoj KumarDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Heera SinghDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Ranjana Walker MinzDepartment of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Systemic sclerosis (SSc) is a chronic multisystem autoimmune rheumatic disease of unknown etiology. Several studies have established that SSc is triggered by a dynamic interplay between genetic factors and environmental stimuli. In the present study, we aimed to study the association of human leukocyte antigen (HLA) with familial and non-familial SSc patients [limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc)] from North India. Methods: The HLA-A, B, DRB1, and DQB1 genotyping of 150 (70 lcSSc and 80 dcSSc) adult-onset SSc patients and 150 age-gender-matched healthy controls were performed with sequence-specific oligonucleotide (SSO) typing kits using the luminex platform. HLA typing for HLA class I (A, B, and C) and II (DRB1, DQB1, and DPB1) in five North Indian families consisting of parent-child/sibling pairs affected with SSc or overlap syndrome was performed by Next Generation Sequencing (NGS) with Illumina MiniSeq. Rseults: Among the non-familial SSc patients, HLA- DRB1*11 ( Discussion: HLA DRB1*11 (risk allele) and DRB1*12 (protective allele) were found to be strongly associated with non-familial SSc patients and partially explain the disease's familial clustering, supporting the susceptible genetic background theory for SSc development. The study also indicates the HLA allele as a common genetic risk factor in distinct autoimmune diseases contributing to overlap syndrome or polyautoimmunity.

Indexed as

Scleroderma, DiffuseScleroderma, SystemicAdultHistocompatibility Antigens Class IHLA-DRB1 ChainsHumansTertiary Care CentersHistocompatibility Antigens Class IHLA-DRB1 ChainsdcSScHLAlcSScphenotypeSSc

Identifiers

PMID37781395
PMCPMC10533912
OpenAlexW4386699229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.